To investigate wheter 50 Hz magnetic field (MF) exposure has any assisting effect on development or growth of DMBA-induced breast tumors in rats.
Exposure | Parameters |
---|---|
Exposure 1:
50–60 Hz
Exposure duration:
24 h/day, 7 days/week for 91 days
|
|
Animals were treated in 4 groups: i) application of dimethylbenz[a]anthracene + EMF exposure ii) application of dimethylbenz[a]anthracen, no EMF exposure iii) EMF exposure iv) neither application of dimethylbenz[a]anthracen nor EMF exposure
Frequency | 50–60 Hz |
---|---|
Type | |
Waveform | |
Exposure duration | 24 h/day, 7 days/week for 91 days |
Measurand | Value | Type | Method | Mass | Remarks |
---|---|---|---|---|---|
magnetic flux density | 100 µT | - | measured | - | - |
A total of 216 rats were used in this study, divided into four groups: Group A) 99 animals, DMBA treated, MF exposed. Group B) 99 animals, DMBA treated, MF sham-exposed. Group C) 9 animals, non-DMBA-treated, MF exposed. D) 9 animals, non-DMBA-treated, MF-sham-exposed.
The first DMBA (5mg/rat) application occured prior exposure and was followed by three more applications in a weekly interval up to a total doses of 20 mg/rat.
Histopathological examination was carried out after 91 days of exposure/sham-exposure. MF-exposed, DMBA-treated animals exhibits significantly more macroscopically visible mammary tumors than DMBA-treated sham-exposed controls. Tumor size was significantly larger in MF-exposed rats, too. The number of neoplastic and non-neoplasic lesions did not significantly differ between groups. In MF-exposed groups, significantly more animals exhibit malignant mammary tumors. The data demonstrate that long-term 50 Hz MF exposure of DMBA treated femal rats promotes the growth and progression of mammary tumors, while tumor incidence is not effected.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.